David Peritt

David Peritt

Company: Lupagen

Job title: Founder & Chief Scientific Officer


Panel Discussion: Opportunities & Challenges to Optimize In Vivo RNA Engineering 10:30 am

Elucidating the opportunities for in vivo cell therapy to minimize current ex vivo bottlenecks and the role of RNA engineering in producing versatile therapies Achieving a transient vs. longer term effect for different indications with RNA modification Maintaining consistent in vivo production of RNA to yield long-term responsesRead more

day: Day Two

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.